Diving Into The Deep
Based in Cambridge, MA and New York, NY, Phase1Oncology is a boutique consulting firm that focuses on bridging the gaps between pre-clinical oncology drug development and first-in-human clinical trials; also bridging the gaps between your management team and our team of seasoned oncologists, statisticians, regulatory and other experts.
Being cognizant of the diverse needs of pharmaceutical and biotech companies – from a startup to a mature pharma – we custom design our phase 1 program to accurately address your needs and your budget. In working with us, you can be as involved as you desire, or you can let us do everything for you, from drug development strategy to the end of Phase 1 study of your compound. In the end, you will receive a comprehensive study report and our recommendation for the next steps in the clinical development of your product.
Data-Driven Analysis
Human Data Science is a new way for life sciences companies to rethink the future of healthcare. By applying data science to the continuous advancement of human science, decisions become more precise. More relevant. Even more creative.
Success of Phase 1 oncology trials is solely dependant on the experience of people who manage every step of this path.
Meet Our Team
Our management team is composed of seasoned oncology drug development experts with a passion for creating innovative solutions for products that are about to enter the phase 1 testing. We are a highly complementary team, and we are proud to lead your product’s path into its clinical phase.
Discover The Future
Our vision is focused on efficient phase 1 drug development for new oncology products, transitioning your products from the bench to the bedside.